Stocks · Healthcare · Biotechnology
4D Molecular Therapeutics, Inc. FDMT
$13.67 -1.23% Close, Oct 2, 2026 · NASDAQ · Market cap $714.6M
Strong trend
Next earnings report: Nov 10, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $92.0M, up 278712.1% from a year earlier, slowing from 383560.9% a quarter earlier.
- Operating margin widened to -214.2% from -667654.5% a year earlier.
- The diluted share count rose 25.6% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 1%
- Revenue growth, 3-year CAGRTop 3%
- Revenue growth accelerationBottom 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 30%
- Gross marginBottom 27%
- Operating marginBottom 23%
- Accruals (lower is better)Bottom 40%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 33%
- Free-cash-flow yieldBottom 23%
- EBITDA / enterprise valueBottom 24%
- Sales / enterprise valueBottom 37%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 25%
- 6-month returnTop 22%
- 1-year return vs S&P 500Top 25%
- Distance from 52-week highTop 31%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 14%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 48%
- Upside to consensus price targetTop 34%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 28%
- Maximum drawdown, 3 yearsBottom 9%
- Beta vs S&P 500 (lower is better)Top 26%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 383560.9% | 278712.1% | ↓ |
| Gross margin | -390560.6% | 42.0% | ↑ |
| Operating margin | -667654.5% | -214.2% | ↑ |
| FCF margin | -514584.8% | -170.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 278712.1% | 383560.9% | ↓ | Top 1% |
| Gross margin | 42.0% | -390560.6% | ↑ | Bottom 27% |
| Operating margin | -214.2% | -667654.5% | ↑ | Bottom 23% |
| Net margin | -194.7% | -594375.8% | ↑ | — |
| Free-cash-flow margin | -170.3% | -514584.8% | ↑ | — |
| Return on invested capital | -43.8% | — | Bottom 30% | |
| Revenue growth, 3-year CAGR | 200.9% | — | Top 3% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 22.2%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -20.52%
- Shareholder yield
- -20.52%
- Share count change, 1 year
- +25.6%
- Share count change, 3-year CAGR
- +22.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- +44.0%
- Average 2-day reaction, last 8
- -1.1%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $29.67
- Target vs current price
- +117.0%
- Analysts with a rating
- 14
- Share rating Buy or Strong Buy
- 79%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -2.0% | -1.9% | +41.2% | +13.6% | — |
| May 7, 2026 | -4.1% | -4.7% | +0.3% | -3.9% | -3.2% |
| Mar 18, 2026 | +181.1% | -0.6% | +6.6% | +13.5% | +2.7% |
| Nov 10, 2025 | +1.0% | -3.1% | +2.8% | +5.5% | -20.1% |
| Aug 11, 2025 | -11.4% | -1.8% | +29.0% | +23.8% | +99.3% |
| May 8, 2025 | -2.4% | +3.8% | +0.3% | +25.3% | +67.9% |
| Feb 28, 2025 | -12.5% | +1.1% | -7.6% | -20.5% | -22.1% |
| Nov 13, 2024 | -17.9% | -2.0% | +10.2% | -12.3% | -41.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.04 | -$1.02 | -2.0% | $3.8M |
| May 7, 2026 | -$1.01 | -$0.97 | -4.1% | $3.0M |
| Mar 18, 2026 | $0.43 | -$0.53 | +181.1% | $85.1M |
| Nov 10, 2025 | -$1.01 | -$1.02 | +1.0% | $90,000 |
| Aug 11, 2025 | -$0.98 | -$0.88 | -11.4% | $15,000 |
| May 8, 2025 | -$0.86 | -$0.84 | -2.4% | $14,000 |
| Feb 28, 2025 | -$0.90 | -$0.80 | -12.5% | $1,000 |
| Nov 13, 2024 | -$0.79 | -$0.67 | -17.9% | $3,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 7.43× | — | — | Bottom 37% |
| Free-cash-flow yield | -21.92% | — | — | Bottom 23% |
| Earnings yield | -19.90% | — | — | Bottom 33% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 40
- Days above the 200-day average
- 46
- 50-day average slope (20 days)
- +7.8%
- 200-day average slope (20 days)
- +3.6%
- Distance from 50-day average
- +2.0%
- Distance from 200-day average
- +30.9%
- RSI (14)
- 44.4
- Relative volume
- 1.10×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 69.5%
- Volatility vs own 5-year history
- 24th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.68
- Correlation with S&P 500
- 0.13
- Current drawdown from 1-year high
- -18.4%
- Maximum drawdown, 3 years
- -93.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 11, 2021 | Apr 8, 2025 | -95.2% | 1043 days | Not yet recovered |
| Dec 18, 2020 | Jan 6, 2021 | -23.6% | 11 days | 8 days (Jan 19, 2021) |
| Jan 19, 2021 | Jan 28, 2021 | -14.2% | 7 days | 5 days (Feb 4, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $714.6M
- EPS, diluted (TTM)
- -$2.72
- Revenue (TTM)
- $92.0M
- 52-week range
- $6.96 – $16.93
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $18.0M | $3.1M | $20.7M | $37,000 | $85.2M |
| Gross profit | -$43.3M | -$77.1M | -$76.4M | -$141.3M | $77.6M |
| Operating income | -$71.3M | -$110.0M | -$112.9M | -$187.8M | -$159.5M |
| Net income | -$71.3M | -$107.5M | -$100.8M | -$160.9M | -$140.1M |
| EPS (diluted) | -$2.46 | -$3.12 | -$2.58 | -$2.98 | -$2.42 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3,000 | $1,000 | $14,000 | $15,000 | $90,000 | $85.1M | $3.0M | $3.8M |
| Net income | -$43.8M | -$49.7M | -$48.0M | -$54.7M | -$56.9M | $19.4M | -$68.8M | -$72.9M |
| EPS (diluted) | -$0.79 | -$0.90 | -$0.86 | -$0.98 | -$1.01 | $0.34 | -$1.01 | -$1.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$69.1M | -$86.7M | -$75.8M | -$134.6M | -$109.1M |
| Capital expenditure | -$9.1M | -$11.5M | -$2.8M | -$3.8M | -$536,000 |
| Free cash flow | -$78.2M | -$98.2M | -$78.6M | -$138.4M | -$109.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $114.3M | $3.1M | $156.8M | $331.4M | $113.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $361.3M
- Total assets
- $492.6M
- Total liabilities
- $85.0M
- Total debt
- $39.2M
- Net debt
- -$31.2M
- Shareholders’ equity
- $407.7M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 12,008,645
- Days to cover
- 18.55
- Change vs previous report
- -0.5%
FINRA short interest, settlement date Sep 15, 2026.